BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell differentiation
,
Influenza
,
Lung
,
Neocentromeres
,
Fenofibrate
,
rs3825942
,
CYP51
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
INK4a
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Plasma cell of spleen
Parotid gland
Skeletal muscle psoas
Microglial cell
Ascending colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Disease due to Papilloma virus
Human papilloma virus infection
Skin cancer
Uterine cancer
Inflammatory disease of liver
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
AMI-1 compound
Lincomycin
oxaprozin
sodium selenate
pyridine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
NR5A1
BMPR2
RHOC
AARS
CDKN1B
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
The ARF GTPase regulatory network in collective invasion and metastasis.
TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcom…
STED imaging of endogenously tagged ARF GTPases reveals their distinct nanoscale localizations.
TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background.
The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Chil…
Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer
Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer
Cyclin-dependent Kinase Inhibitor 2A (Placental Senescence Marker) on Labor-related Signals
A Model for Genetic Susceptibility: Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ